Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Merck's Covid-19 Drug Is a Boon for Wall Street

Wall Street Journal - 1 Oct 2021 16:49
The strong data for Merck's experimental Covid-19 antiviral treatment has rejuvenated the company's stock price and could jump-start the moribund biotech sector.
Full Article at Wall Street Journal

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard